Lisanti Capital Dumps $5.4 Million Alphatec Stake as Medical Device Maker Struggles

On May 6, 2026, Lisanti Capital Growth disclosed in an SEC filing that it sold out its entire stake in Alphatec (NASDAQ:ATEC), an estimated $5.42 million trade based on quarterly average pricing.According to a recent SEC filing dated May 6, 2026, Lisanti Capital Growth liquidated its entire position in Alphatec, selling 372,407 shares. The estimated transaction value was $5.42 million, calculated using the average unadjusted closing price for the first quarter of 2026. The quarter-end value of the position decreased by $7.84 million, capturing both the trade and share price movement over the period.Alphatec is a U.S.-based medical technology company specializing in innovative solutions for the surgical treatment of spinal disorders. The company leverages a direct sales model and a network of independent distributors to deliver a broad range of proprietary devices and biologics to healthcare providers nationwide.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool